Explore the Galaxy of Future Medicine
We provide the world’s leading target screening, structural characterization, and functional profiling services for potential drug targets to generate a faster track to drugability. We offer platforms of computer-aided, protein profiling, functional analyzing, digital imaging and high/medium throughput screening.
We offer a range of customized screening approaches to deliver high-quality, validated hits. Our hit identification approaches include virtual screening, high throughput screening, high content screening, flow cytometry, fragment screening and structural aided drug design.
We provide hit to lead service to help you determine the effects, biophysical characters, structure-activity relationships (SAR), and mechanism of actions (MOA) of compounds. Our medicinal chemists deliver the most high-quality lead series to our clients within agreed timelines across a broad range of target classes. By this project, compound scope for further optimization is narrowed.
We detail characterize lead series in this process. We help you evaluate drug potency, absorption, distribution, metabolism, excretion and toxicology by various in vitro and in vivo studies. Lead optimization gives the better quality of lead molecules. These optimized molecules may subsequently be developed as drug(s).
Help a pharmaceutical company obtains permission to ship an experimental drug. If the application is cleared, the candidate drug usually enters the clinical trial stages.
